使RNA-seqMRD:

Yuyue Ren1, Ming Liu2, Jiancheng Fang2

  • 1Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.

Cancer gene therapy
|October 24, 2025
PubMed
概括

与向DNA测序相比,RNA测序 (RNA-seq) 提供了一种更敏感的方法来监测多发性骨髓瘤 (MM) 患者的最小残留疾病 (MRD). 这种方法有助于通过检测克隆免疫球蛋白基因表达来预测患者的预后.